NCT00935090
- Conditions
- Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +101 more
- Locations
-
- Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
Clinical trial condition
Lymphoma, Extranodal NK-T-Cell
Explore clinical trials studying Lymphoma, Extranodal NK-T-Cell. Study availability and eligibility vary by location and protocol.
157 public trials
17 recruiting studies
Lymphoma, Extranodal NK-T-Cell trial results
NCT07000617
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- National Cancer Center / Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing, China
- Peking University Cancer Hospital Beijing, China
- Peking University International Hospital Beijing, China
NCT06824883
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT06732492
- Conditions
- CART Therapy, CD7-positive Relapsed/Refractory Lymphoid Hematologic Malignancies, Lymphoma, +6 more
- Locations
-
- Union Hospital Wuhan, Hubei, China
NCT05662540
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +4 more
- Locations
-
- Ruijin Hospital Shanghai, Shanghai Municipality, China
NCT05833893
- Conditions
- Advanced Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +6 more
- Locations
-
- ChinaPLAGH Beijing, Haidian, China
NCT02859402
- Conditions
- Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +13 more
- Locations
-
- Dong-A University Busan, South Korea
- Keimyung University Dongsan Medical Center Daegu, South Korea
Not Yet Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
NCT07727083
- Conditions
- Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
NCT07678229
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Extranodal NK/T-cell Lymphoma, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Not Yet Recruiting
TR115 VS Investigator's Choice in Relapsed/Refractory Peripheral T/NK Cell Lymphoma
NCT07639879
- Conditions
- Lymphoma, Lymphoma, Extranodal NK-T-Cell, Lymphoma, Non-Hodgkin, +5 more
- Locations
-
- Peking University Cancer Hospital Beijin, Beijing Municipality, China